Chest
Selected ReportsAdenosine-induced Torsades de Pointes
Section snippets
CASE REPORT
A 62-year-old man was taken to the operating room for treatment of a diverticular abscess involving the left iliopsoas muscle. Postoperatively, he demonstrated multiple episodes of atrial flutter and paroxysmal supraventricular tachycardia with heart rates up to 170 beats per minute. In order to control the recurrent episodes of supraventricular tachycardia, the patient eventually required a continuous infusion of procainamide, 2 mg/min, and esmolol, 50 Digitalis also was utilized both for rate
DISCUSSION
Adenosine recently was approved by the Food and Drug Administration for intravenous use in patients with paroxysmal supraventricular tachycardia. It is particularly effective in those patients whose supraventricular tachycardia is the result of atrioventricular reciprocating or atrioventricular nodal reentrant tachycardia.1 In many circumstances, it has supplanted verapamil as the treatment of choice for supraventricular dysrhythmia where the underlying electrophysiologic mechanism is unclear.
REFERENCES (9)
- et al.
Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias
J Am Coll Cardiol
(1985) Ventricular fibrillation precipitated by carotid sinus pressure: case report and review of the literature
Am Heart J
(1972)Torsades de Pointes: a review
Am J Emer Med
(1991)- et al.
Torsades de point after intravenous adenosine in the presence of prolonged QT syndrome
Am Heart J
(1992)
Cited by (32)
Adenosine triphosphate-induced life-threatening arrhythmia
2023, Journal of Cardiology CasesTorsades de pointes after adenosine administration
2016, Journal of ElectrocardiologyAdenosine Induces Ventricular Arrythmias in Hearts With Chronic Chagas Cardiomyopathy
2010, Revista Espanola de CardiologiaAdenosine-induced cardiac arrest during intraoperative cerebral aneurysm rupture
2010, World NeurosurgeryAdenosine
2007, Complications in AnesthesiaAdenosine
2006, Complications in Anesthesia
The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Department of the Army or the Department of Defense.